Read-Gene (WAR:RDG) Total Operating Expense : zł8.69 Mil (TTM As of Sep. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Read-Gene Total Operating Expense?

Read-Gene's Total Operating Expense for the three months ended in Sep. 2023 was zł1.10 Mil. Read-Gene's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was zł8.69 Mil.

Read-Gene Total Operating Expense Historical Data

The historical data trend for Read-Gene's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Read-Gene Total Operating Expense Chart

Read-Gene Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Operating Expense

Get a 7-Day Free Trial

5.21

5.44

5.02

5.74

5.90

Read-Gene Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Operating Expense	Get a 7-Day Free Trial															0.98	3.49	1.68	2.42	1.10

Read-Gene Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was zł8.69 Mil.

Read-Gene Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Read-Gene's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Read-Gene (WAR:RDG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ulica Alabastrowa 8, Grzepnica, Dobra, POL, 72-003

Website

http://www.read-gene.com

Read-Gene SA treats each patient individually based on genetic tests. The company's segments include chemoprevention, clinical trials and genetic tests. It also engaged in developing technologies to commercialize methods to detect, prevent and treat malignant tumours.

Read-Gene (WAR:RDG) Headlines

No Headlines